IMMURON LTD-SPON ADR (IMRN) Stock Price, Quote, News and Overview
NASDAQ:IMRN - Nasdaq - US45254U1016 - ADR - Currency: USD
IMRN Quote, Performance and Key Statistics
NASDAQ:IMRN (2/21/2025, 8:00:01 PM)
1.9
+0.01 (+0.53%)
The current stock price of IMRN is 1.9 USD. In the past month the price decreased by -7.32%. In the past year, price increased by 7.95%.
IMRN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About IMRN
Company Profile
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company is headquartered in Melbourne, Victoria. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
Company Info
IMMURON LTD-SPON ADR
L 3 62 Lygon St
Melbourne VICTORIA 3053 AU
CEO: Jerry Kanellos
Employees: 7
Company Website: https://www.immuron.com.au
Investor Relations: http://www.immuron.com/investor-centre/business-overview/
Phone: 61398245254
IMMURON LTD-SPON ADR / IMRN FAQ
What is the stock price of IMMURON LTD-SPON ADR today?
The current stock price of IMRN is 1.9 USD. The price increased by 0.53% in the last trading session.
What is the ticker symbol for IMMURON LTD-SPON ADR stock?
The exchange symbol of IMMURON LTD-SPON ADR is IMRN and it is listed on the Nasdaq exchange.
On which exchange is IMRN stock listed?
IMRN stock is listed on the Nasdaq exchange.
What is IMMURON LTD-SPON ADR worth?
IMMURON LTD-SPON ADR (IMRN) has a market capitalization of 10.83M USD. This makes IMRN a Nano Cap stock.
How many employees does IMMURON LTD-SPON ADR have?
IMMURON LTD-SPON ADR (IMRN) currently has 7 employees.
What are the support and resistance levels for IMMURON LTD-SPON ADR (IMRN) stock?
IMMURON LTD-SPON ADR (IMRN) has a support level at 1.87 and a resistance level at 1.97. Check the full technical report for a detailed analysis of IMRN support and resistance levels.
Should I buy IMMURON LTD-SPON ADR (IMRN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IMRN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IMRN, evaluating the profitability, health, valuation and growth aspects
- IMMURON LTD-SPON ADR (IMRN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IMMURON LTD-SPON ADR (IMRN) Sales and EPS estimates to see what analysts future expectations are.
- IMMURON LTD-SPON ADR (IMRN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IMMURON LTD-SPON ADR (IMRN) Insider and Institutional Ownership to learn about the owners and their transactions.
- IMMURON LTD-SPON ADR (IMRN) Stock Chart to make your own analysis
- IMMURON LTD-SPON ADR (IMRN) Latest news and press-releases to stay up to date.
Does IMMURON LTD-SPON ADR (IMRN) stock pay dividends?
IMRN does not pay a dividend.
When does IMMURON LTD-SPON ADR (IMRN) report earnings?
IMMURON LTD-SPON ADR (IMRN) will report earnings on 2025-02-26.
What is the Price/Earnings (PE) ratio of IMMURON LTD-SPON ADR (IMRN)?
IMMURON LTD-SPON ADR (IMRN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.78).
What is the Short Interest ratio of IMMURON LTD-SPON ADR (IMRN) stock?
The outstanding short interest for IMMURON LTD-SPON ADR (IMRN) is 0.43% of its float. Check the ownership tab for more information on the IMRN short interest.
IMRN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to IMRN. When comparing the yearly performance of all stocks, IMRN turns out to be only a medium performer in the overall market: it outperformed 61.52% of all stocks.
IMRN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IMRN. The financial health of IMRN is average, but there are quite some concerns on its profitability.
IMRN Financial Highlights
Over the last trailing twelve months IMRN reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS decreased by -83.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.61% | ||
| ROE | -54.58% | ||
| Debt/Equity | 0 |